BCR and myeloid sarcoma: The screen (Table S2) suggested that expression levels of miR-132 (p = 0.0079) and miR-210 (p = 0.0362) were higher in MS B cells compared to HS B cells upon ‘dual BCR+CD40 stimulation’, and that miR-142-5p expression was more highly expressed in MS B cells upon ‘CD40 stimulation’ (p = 0.0317).